V-TAD for Patients Greater Than Fifty Years of Age With Acute Non-Lymphocytic Leukemia.

The effect of complete remission (CR) and CR with incomplete platelet recovery (CRp) on outcome in acute myeloid leukemia: a combined eastern cooperative oncology group (ECOG), Southwest Oncology Group (SWOG), and M.D. Anderson Cancer Center study

Journal of Clinical Oncology 28(10):1766-1771;

Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia.

D Head;KJ Kopecky;J Weick;JC Files;D Ryan;K Foucar;M Montiel;J Bickers;A Fishleder;M Miller;C Spier;C Hanson;M Bitter;R Braziel;G Mills;J Welborn;W Williams;J Hewlett;C Willman;FR Appelbaum Blood 86(5):1717-1728

Treatment of acute myelogenous leukemia in patients over 50 years of age with V-TAD: A Southwest Oncology Group study

CL Bigelow;K Kopecky;JC Files;D Head;DA Lipschitz;M Grever;FR Appelbaum American Journal of Hematology 48:228-232

Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.

DR Head;KJ Kopecky;C Willman;FR Appelbaum Leukemia 8(Suppl.2):S38-S41

Reply to comments by Fenaux and Warrell.

DR Head;KJ Kopecky;C Willman;FR Appelbaum Leukemia 8(Suppl.2):S62

Survival with cytotoxic therapy in acute promyelocytic leukemia. A Southwest Oncology Group report.

DR Head;K Kopecky;J Hewlett;J Weick;D Ryan;J Files;J Bickers;K Foucar;M Montiel;A Fishleder;J Welborn;G Mills;E Billeter;C Willman;F Appelbaum Blood 78:268a